[Activity of prodigiozan by various routes of administration and during non-specific stimulation of local (regional) defense mechanisms].
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003864:Depression, Chemical; D004195:Disease Models, Animal; D004927:Escherichia coli Infections / Q000401:mortality / Q000517:prevention & control*; D005260:Female; D006614:Hindlimb; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D051379:Mice; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage* / Q000627:therapeutic use; D012706:Serratia marcescens; D013203:Staphylococcal Infections / Q000401:mortality / Q000517:prevention & control*
D000970:Antineoplastic Agents; D011135:Polysaccharides, Bacterial
Aktivnost' prodigiozana pri raznykh metodakh ego vvedeniia i nespetsificheskaia stimuliàtsiiâ mestnykh (regionarnykh.